Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today issued ...
The scandal has put the spotlight on Minnesota’s Democratic Gov. Tim Walz and the state’s Somali population, the latest immigration enforcement target of the Trump administration. At the center of the ...
HONOLULU — A novel “moderate-affinity iron chaperone” known as ATH434 (Alterity Therapeutics) may slow disease progression in patients with multiple system atrophy (MSA), new research suggested. The ...
AI is slowly making its way into every facet of life, and that means more and more fields are being manned by machines that can't be held accountable. In many cases, AI going wrong is normally ...
VALBY, Denmark, Oct. 2, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced that pipeline developments regarding amlenetug, a novel investigational molecule for the potential treatment of ...
📖 提示：普通读者请访问在线站点 wiki.mpsteam.cn。本文件主要面向开发者与贡献者。 Multiple_personality_system_wiki/ ├─ README.md ...
Final participant randomized to complete enrollment in Phase 1 clinical trial assessing safety of investigational gene therapy AB-1005 delivered to the putamen in patients with multiple system atrophy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results